JJournal for ImmunoTherapy of Cancer@jitcancerScore6060Immunoprevention continues to gain momentum as O. Nadeem shares, “Ciltacabtagene autoleucel in high-risk smoldering myeloma: Results from...Same topic #JITC · 1 personHeat 00 likes0 replies0 reposts
JJournal for ImmunoTherapy of Cancer@jitcancerScore6060Advancing CAR T-cell strategies for solid tumors remains a key focus in IO and a recent #JITC study by Diego Salas-Benito et al explores ...Same topic #JITC · 1 personHeat 3426 likes1 reply7 reposts
